Overview

Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The investigators propose to test the efficacy of ketorolac nasal spray versus sumatriptan nasal spray versus placebo for acute abortive therapy of migraine head pain as well as for migraine associated symptoms including nausea and allodynia.
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
American Regent, Inc.
Luitpold Pharmaceuticals
Treatments:
Ketorolac
Ketorolac Tromethamine
Sumatriptan